Studies suggest that physiologic ghrelin responses to fasting and postprandial states are blunted or nonexistent in cancer patients (Roth et al. 2011, Zub-Pokrowiecka et al. 2011) and in rats with hepatoma cells (Portau et al. 2011). This evidence concerns the gene GHRL and hepatocellular carcinoma.